Brain Imaging Study for Alzheimer's Disease Diagnosis
Part of Brain & nervous system, Mental health clinical trials.
This study tests a new type of brain scan ([18F]F-AraG PET) that may help detect Alzheimer's disease earlier or more accurately. Researchers will take pictures of your brain to see if this scan can identify changes related to Alzheimer's.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 55 or older
- You have had a brain MRI (magnetic resonance imaging) scan in the past 6 months, or you're willing to have one for this study
- You can lie still in a PET imaging machine for the scan and follow all study procedures
- You have a diagnosis of possible or probable Alzheimer's disease based on standard medical guidelines
- You have a family member or close friend who spends significant time with you and can report on your daily activities
- If you can still have children, you agree to use effective birth control for 1 day after the imaging scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special brain scans (PET scans) to look for proteins linked to Alzheimer's disease. It aims to improve diagnosis and track how the disease progresses over time.
This study uses brain scans (PET) to look at changes in the brain that may be related to memory problems or Alzheimer's disease. It aims to improve understanding of the disease and may help develop better treatments.
This trial uses a new type of PET scan to look for specific proteins in the brain that are linked to Alzheimer's disease. It will help doctors see how these proteins relate to cognitive decline and compare scans from people with normal thinking to those with memory problems.
This trial uses special PET scans to see amyloid and tau proteins in the brain, which are linked to Alzheimer's. It aims to find these changes early, in people with mild memory problems or early-stage Alzheimer's.
This study uses a special brain scan (PET imaging) and blood tests to look for early signs of Alzheimer's and other brain diseases. It aims to improve how we detect and understand these conditions.
This study tests a new type of brain scan (called [18F]Flortaucipir PET) that may help detect early signs of Alzheimer's disease. Researchers want to make sure the scan is safe and works well in Chinese patients aged 50–85 with normal thinking, mild memory problems, or Alzheimer's disease.
Hear when a new Alzheimer Disease (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.